Skip to main content
Clinical Trials/IRCT2012081310573N1
IRCT2012081310573N1
Completed
N/A

Comparison of cardiovascular outcomes (repeated infarction, infarct size, hemorrhage, and death) of intracoronary abciximab or intravenous eptifibatide administration during percutaneous coronary intervention of ST-segment elevation myocardial infarction

Cardiovascular Research Center, Shahid Beheshti University of Medical sciences0 sites40 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
ST-segment elevation myocardial infarction.
Sponsor
Cardiovascular Research Center, Shahid Beheshti University of Medical sciences
Enrollment
40
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Cardiovascular Research Center, Shahid Beheshti University of Medical sciences

Eligibility Criteria

Inclusion Criteria

  • ST elevation myocardial infarction (MI)
  • Exclusion criteria: patients presenting with ST\-elevation myocardial infarction after 12 hours from symptoms onset; patients presenting with vasospastic angina (determined by resolution of ST segment elevation, and relief of symptoms after intravenous administration of nitroglycerin); patients presenting with non\-ST elevation MI; contraindications for antiplatelets such as bleeding disorder including gastrointestinal bleeding, hematuria, or any known bleeding tendency either inherited or acquired; thrombocytopenia (Platelet count less than 100\.000 per microliter; recent (less than 6 months) stroke; intracranial hemorrhage at any time in patient's life or any known intracranial malformation; cardiogenic shock; left bundle branch block changes on ECG.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials